Fresenius SE Price to Sales Ratio 2016-2023 | FSNUY
Historical PS ratio values for Fresenius SE (FSNUY) over the last 10 years. The current P/S ratio for Fresenius SE as of May 02, 2024 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Fresenius SE P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 0.00 | nan | ||
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $16.978B | $24.011B |
| Fresenius SE & Co is a health care company. It offers products and services for dialysis, hospitals and outpatient treatment. The company's business segment consists of Fresenius Medical Care is engaged in treating with chronic kidney failure; Fresenius Helios is a hospital operator; Fresenius Kabi supplies essential drugs, clinical nutrition products, medical devices and services and Fresenius Vamed plans, develops and manages healthcare facilities. Fresenius SE & Co is headquartered in Bad Homburg, Germany. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quest Diagnostics (DGX) | United States | $15.146B | 15.65 |
| DaVita (DVA) | United States | $12.474B | 15.49 |
| Chemed (CHE) | United States | $8.473B | 26.26 |
| Encompass Health (EHC) | United States | $8.354B | 21.50 |
| Elanco Animal Health (ELAN) | United States | $6.655B | 15.14 |
| Option Care Health (OPCH) | United States | $5.195B | 19.66 |
| RadNet (RDNT) | United States | $3.817B | 103.32 |
| Amedisys (AMED) | United States | $3.020B | 21.40 |
| LifeStance Health (LFST) | United States | $2.496B | 0.00 |
| Astrana Health (ASTH) | United States | $2.077B | 25.92 |
| Addus HomeCare (ADUS) | United States | $1.611B | 24.48 |
| U.S Physical Therapy (USPH) | United States | $1.562B | 40.48 |
| Pennant (PNTG) | United States | $0.636B | 37.19 |
| Aveanna Healthcare Holdings (AVAH) | United States | $0.437B | 0.00 |
| Atai Life Sciences (ATAI) | Germany | $0.357B | 0.00 |
| Daxor (DXR) | United States | $0.047B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.027B | 0.00 |
| ATI Physical Therapy (ATIP) | United States | $0.019B | 0.00 |
| Psychemedics (PMD) | United States | $0.015B | 0.00 |
| Ontrak (OTRK) | United States | $0.013B | 0.00 |
| Novo Integrated Sciences (NVOS) | United States | $0.011B | 0.00 |
| IMAC Holdings (BACK) | United States | $0.004B | 0.00 |